Research Center

Research Center

Ortho Illinois has long held a commitment to continuing medical education and providing university-level care.  In 2006, it was a natural next step to formalize a program that allows our physicians to participate in the process that contributes to medical research and makes revolutionary new products and treatments possible.

Be a part of our clinical studies:

Current studies

If interested, please call the Ortho Illinois Research Department at 815-847-7078.


  • A prospective, randomized, active treatment=controlled, evaluator-blinded study to evaluate the Hyalofast® device with autologous bone marrow aspirate concentrate in the treatment of articular knee cartilage defect lesions in comparison to microfracture treatment.
  • MD conducting the study: Dr. Van Thiel
  • If interested, call Gaby at 815-381-7456



  • a Phase 3, randomized, double-blind, study comparing Upadacitinib (ABT-494) to placebo and to Adalimumab in subjects with active Psoriatic Arthritis who have a history of inadequate response to at least one disease-modifying anti-rheumatic drug.
  • MDs conducting the study: Dr. Andrew Jasek and Dr. Olga Goodman
  • If interested, please call Andrea at 815-484-6942


  • Collect and document use patterns, effectiveness, and safety of all treatments currently used in the management of rheumatoid arthritis which will be maintained in a national database, the Consortium of Rheumatology Researchers of North America (CORRONA), for purposes related to drug safety, clinical outcomes and market research.
  • MD conducting the study: Dr. Olson
  • If interested, please call Lisa at 847-7078


  • A Prospective, Non-Randomized, Post Market study to assess the effectiveness of the Rotation Medical Bioinductive Implant used in the treatment of supraspinatus tendon tears.
  • MD conducting the study: Dr. Trenhaile
  • If interested, please call Gaby at 815-381-7456

Upcoming studies:



About Clinical Research:

Clinical research studies are biomedical or health-related studies that involve patients with a targeted diagnosis. Depending on the specific study, there are usually 50-100 sites nationally or internationally participating in a particular study. Sites are carefully selected based on state-of-the-art diagnostic and facility criteria and by the commitment demonstrated by the physicians involved in top quality patient care.

By participating in national and international clinical research studies at the Phase II-IV levels, Ortho Illinois physicians have access to new treatment options for patients on a local level who have not experienced improvement through other treatments.

Currently, Ortho Illinois has executed over 80 clinical research and post market studies. We are proud to participate in the first-in-class drug studies for the treatment of rheumatoid arthritis, notably Xejanz® and Otezla®.  We seek advanced medical device studies including biodegradable materials or using the body’s own stem cells to heal joint damage.   By gaining years’ of experience using cutting edge technologies, our physicians already have the expertise you desire once a new drug or device is approved by the FDA.

In addition to expanding physicians’ experience and knowledge, being in a clinical trial offers great benefits to patients.  Study participants gain access to new research treatments before FDA approval or availability, receive more services, are assessed more frequently, and have a more active role in their health care.  Participating in a research study offers financial as well as health benefits, especially for those patients with high co-pays or who do not have healthcare coverage.  All laboratory, medication, and physician costs specific to the study are covered for the patient participant by the company conducting the study.

For further information about research studies contact:

Lisa Foti, MS, Director of Research at 815-847-7078.

Gaby Rutiaga, BS, Research Coordinator, at 815-381-7456

Andrea Windsor, RN, BSN, Research Nurse Coordinator, at 815-484-6942